{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:14:30Z","timestamp":1763662470268},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.dld.2003.09.018","type":"journal-article","created":{"date-parts":[[2003,12,4]],"date-time":"2003-12-04T11:59:03Z","timestamp":1070539143000},"page":"7-12","source":"Crossref","is-referenced-by-count":19,"title":["Empirical Helicobacter pylori \u201crescue\u201d therapy after failure of two eradication treatments"],"prefix":"10.1016","volume":"36","author":[{"given":"J.P","family":"Gisbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L","family":"Gisbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M","family":"Pajares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2003.09.018_BIB1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1046\/j.1365-2036.2002.01276.x","article-title":"Helicobacter pylori \u2018rescue\u2019 regimen when proton pump inhibitor-based triple therapies fail","volume":"16","author":"Gisbert","year":"2002","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000050668","article-title":"Helicobacter pylori therapy: first-line options and rescue regimen","volume":"19","author":"Gisbert","year":"2001","journal-title":"Dig. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.dld.2003.09.018_BIB3","doi-asserted-by":"crossref","first-page":"I40","DOI":"10.1136\/gut.45.2008.i40","article-title":"Treatment after failure: the problem of \u201cnon-responders\u201d","volume":"45","author":"Huang","year":"1999","journal-title":"Gut."},{"key":"10.1016\/j.dld.2003.09.018_BIB4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/bmj.320.7226.31","article-title":"Regular review: treatment of Helicobacter pylori infection","volume":"320","author":"de Boer","year":"2000","journal-title":"Br. Med. J."},{"key":"10.1016\/j.dld.2003.09.018_BIB5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1590-8658(03)00081-1","article-title":"A clinical practice viewpoint: to culture or not to culture Helicobacter pylori?","volume":"35","author":"Zullo","year":"2003","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.dld.2003.09.018_BIB6","unstructured":"Technical annex: tests used to assess Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group, Gut 1997; 41(Suppl 2):S10\u20138."},{"key":"10.1016\/j.dld.2003.09.018_BIB7","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1046\/j.1365-2036.2001.01064.x","article-title":"Alternative antibacterial agents for Helicobacter pylori eradication","volume":"15","author":"Guslandi","year":"2001","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB8","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1046\/j.1365-2036.2000.00833.x","article-title":"Third line treatment for Helicobacter pylori: a prospective, culture-guided study in peptic ulcer patients","volume":"14","author":"Gomollon","year":"2000","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB9","first-page":"386","article-title":"Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole and amoxicillin\u2013influence on treatment outcome","volume":"93","author":"Adamek","year":"1998","journal-title":"Am. J. Gastroenterol"},{"key":"10.1016\/j.dld.2003.09.018_BIB10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1523-5378.1997.tb00085.x","article-title":"Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin","volume":"2","author":"Tompkins","year":"1997","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2003.09.018_BIB11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1590-8658(00)80327-8","article-title":"Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study","volume":"32","author":"Pilotto","year":"2000","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.dld.2003.09.018_BIB12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1746.1998.tb00537.x","article-title":"Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection","volume":"13","author":"Lam","year":"1998","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.dld.2003.09.018_BIB13","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1111\/j.1572-0241.1998.00684.x","article-title":"Guidelines for the management of Helicobacter pylori infection. Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology","volume":"93","author":"Howden","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2003.09.018_BIB14","doi-asserted-by":"crossref","unstructured":"Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter pylori Study Group. Gut 1997;41:8\u201313.","DOI":"10.1136\/gut.41.1.8"},{"key":"10.1016\/j.dld.2003.09.018_BIB15","doi-asserted-by":"crossref","unstructured":"The report of the Digestive Health InitiativeSM. In: Proceedings of the International Update Conference on Helicobacter pylori. Gastroenterology 1997;113:S4\u20138.","DOI":"10.1016\/S0016-5085(97)80003-0"},{"key":"10.1016\/j.dld.2003.09.018_BIB16","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/00042737-199909000-00018","article-title":"Re-treatment after Helicobacter pylori eradication failure","volume":"11","author":"Gisbert","year":"1999","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.dld.2003.09.018_BIB17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(95)92962-2","article-title":"Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection","volume":"345","author":"de Boer","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2003.09.018_BIB18","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1046\/j.1365-2036.2000.00770.x","article-title":"Metronidazole containing quadruple therapy for infection with metronidazole resistant Helicobacter pylori: a prospective study","volume":"14","author":"Graham","year":"2000","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB19","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/S0002-9270(99)00258-0","article-title":"The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti-Helicobacter pylori regimens: a meta-analysis","volume":"94","author":"van der Wouden","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2003.09.018_BIB20","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1523-5378.1999.99307.x","article-title":"Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases","volume":"4","author":"Gomollon","year":"1999","journal-title":"Helicobacter"},{"key":"10.1016\/j.dld.2003.09.018_BIB21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2036.2002.01169.x","article-title":"Current concepts in the management of Helicobacter pylori infection\u2014the Maastricht 2\u20142000 Consensus Report","volume":"16","author":"Malfertheiner","year":"2002","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB22","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/AAC.43.5.1072","article-title":"In vitro anti-Helicobacter pylori activities of new rifamycin derivatives, KRM-1648 and KRM-1657","volume":"43","author":"Akada","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.dld.2003.09.018_BIB23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1128\/AAC.43.6.1497","article-title":"Rifampin and rifabutin resistance mechanism in Helicobacter pylori","volume":"43","author":"Heep","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.dld.2003.09.018_BIB24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2165\/00003495-199447060-00008","article-title":"Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy","volume":"47","author":"Brogden","year":"1994","journal-title":"Drugs"},{"key":"10.1016\/j.dld.2003.09.018_BIB25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1056\/NEJM199807023390116","article-title":"Treatment of antibiotic-resistant Helicobacter pylori","volume":"339","author":"Perri","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.dld.2003.09.018_BIB26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2036.2000.00719.x","article-title":"Rifabutin-based \u2018rescue therapy\u2019 for Helicobacter pylori infected patients after failure of standard regimens","volume":"14","author":"Perri","year":"2000","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00004836-200010000-00007","article-title":"Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience","volume":"31","author":"Bock","year":"2000","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.dld.2003.09.018_BIB28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-230X-1-7","article-title":"Efficacy of Helicobacter pylori eradication therapies: a single centre observational study","volume":"1","author":"Beales","year":"2001","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.dld.2003.09.018_BIB29","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2036.2001.00909.x","article-title":"Rifabutin-based Helicobacter pylori eradication \u2018rescue therapy\u2019","volume":"15","author":"Canducci","year":"2001","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB30","first-page":"58","article-title":"Randomized study of two \u201crescue\u201d therapies for Helicobacter pylori-infected patients after failure of standard triple therapies","volume":"96","author":"Perri","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.dld.2003.09.018_BIB31","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1590-8658(03)00059-8","article-title":"A third-line levofloxacin-based rescue therapy for Helicobacter pylori eradication","volume":"35","author":"Zullo","year":"2003","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.dld.2003.09.018_BIB32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2036.1995.tb00410.x","article-title":"Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer","volume":"9","author":"Reilly","year":"1995","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3109\/00365529709028149","article-title":"Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy","volume":"32","author":"Lerang","year":"1997","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.dld.2003.09.018_BIB34","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000050674","article-title":"A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy","volume":"19","author":"Magaret","year":"2001","journal-title":"Dig. Dis."},{"key":"10.1016\/j.dld.2003.09.018_BIB35","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1365-2036.2000.00685.x","article-title":"Efficacy of a multistep strategy for Helicobacter pylori eradication","volume":"14","author":"Gasbarrini","year":"2000","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB36","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/003655200750022977","article-title":"Cure of Helicobacter pylori infection after failed primary treatment: one-center results from 120 patients","volume":"35","author":"Seppala","year":"2000","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.dld.2003.09.018_BIB37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1365-2036.2000.00674.x","article-title":"Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies","volume":"14","author":"Chan","year":"2000","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.dld.2003.09.018_BIB38","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1046\/j.1365-2036.2001.01028.x","article-title":"A triple therapy regimen after failed Helicobacter pylori treatments","volume":"15","author":"Zullo","year":"2001","journal-title":"Aliment Pharmacol. Ther."}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865803006030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865803006030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,27]],"date-time":"2020-03-27T16:17:21Z","timestamp":1585325841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865803006030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S1590865803006030"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2003.09.018","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}